The Journal of Urology
Volume 182, Issue 6 , Pages 2677-2681, December 2009

Low Annual Caseloads of United States Surgeons Conducting Radical Prostatectomy

  • Caroline J. Savage
  • ,
  • Andrew J. Vickers

      Affiliations

    • Corresponding Author InformationCorrespondence: Department of Epidemiology and Biostatistics; Memorial Sloan-Kettering Cancer Center, 307 East 63rd St., New York, New York 10021 (telephone: 646-735-8142; FAX: 646-735-0011)

Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York

Received 24 March 2009 published online 16 October 2009.

Purpose

It has been clearly demonstrated that surgeons with increased yearly caseloads have lower complication rates. Moreover it has been shown that a surgeon needs to conduct at least 250 radical prostatectomies to maximize cancer control (the surgical learning curve).

Materials and Methods

To determine typical annual radical prostatectomy caseloads of surgeons in the United States we analyzed data from 2 independent data sets for 2005, that of a nationally representative sample (Nationwide Inpatient Sample) and a complete record of all hospital discharges from New York State (Statewide Planning and Research Cooperative System).

Results

More than 25% of United States surgeons conducting radical prostatectomy in 2005 performed only a single procedure. Approximately 80% of surgeons performed fewer than 10 procedures per year and, thus, are unlikely to reach the plateau of the learning curve during their surgical career.

Conclusions

The current pattern of surgical treatment for prostate cancer leads to many patients being treated by surgeons with low annual caseloads, with likely poorer outcomes as a result.

Key Words: prostatectomy, prostatic neoplasms, workload

Abbreviations and Acronyms: NIS, Nationwide Inpatient Sample, SPARCS, Statewide Planning and Research Cooperative System

 

 Supported by the Sidney Kimmel Center for Prostate and Urologic Cancers, by a P50-CA92629 SPORE Grant from the National Cancer Institute and by funds from David H. Koch provided through the Prostate Cancer Foundation.

PII: S0022-5347(09)02056-4

doi:10.1016/j.juro.2009.08.034

The Journal of Urology
Volume 182, Issue 6 , Pages 2677-2681, December 2009